dailyai.report

OpenAI released GPT-Rosalind, a specialized reasoning model built to accelerate the transition from hypothesis to experiment in life sciences. The company currently restricts access to a controlled group of researchers. This niche deployment tests whether reasoning-heavy architectures can solve complex biological problems. Practitioners should monitor if this leads to a broader set of domain-specific models.